Suivre
Akos Gulyban
Akos Gulyban
Medical physicist, Jules Bordet Institute
Adresse e-mail validée de bordet.be
Titre
Citée par
Citée par
Année
EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach
O Matzinger, E Gerber, Z Bernstein, P Maingon, K Haustermans, ...
Radiotherapy and Oncology 92 (2), 164-175, 2009
1532009
Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)
O Matzinger, I Heimsoth, P Poortmans, L Collette, H Struikmans, ...
Acta Oncologica 49 (1), 24-34, 2010
1282010
Acute toxicity of curative radiotherapy for intermediate-and high-risk localised prostate cancer in the EORTC trial 22991
O Matzinger, F Duclos, A Van den Bergh, C Carrie, S Villà, P Kitsios, ...
European journal of cancer 45 (16), 2825-2834, 2009
1152009
Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting
DC Weber, PMP Poortmans, CW Hurkmans, E Aird, A Gulyban, ...
Radiotherapy and Oncology 100 (1), 150-156, 2011
932011
Interobserver variability in delineation of target volumes in head and neck cancer
J van der Veen, A Gulyban, S Nuyts
Radiotherapy and Oncology 137, 9-15, 2019
832019
Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review
O Matzinger, P Poortmans, JY Giraud, P Maingon, T Budiharto, ...
Radiotherapy and Oncology 90 (3), 285-290, 2009
612009
Multisegmented tangential breast fields: a rational way to treat breast cancer
A Gulyb n, Z Sebesty n, R Farkas, T Csere, G Kar csonyi, K D rczy, ...
Strahlentherapie und Onkologie 184 (5), 262-269, 2008
572008
Quality assurance in the EORTC 22033–26033/CE5 phase III randomized trial for low grade glioma: the digital individual case review
A Fairchild, DC Weber, R Bar-Deroma, A Gulyban, PA Fenton, R Stupp, ...
Radiotherapy and Oncology 103 (3), 287-292, 2012
482012
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?
P Berkovic, L Paelinck, Y Lievens, A Gulyban, B Goddeeris, C Derie, ...
Acta Oncologica 54 (9), 1438-1444, 2015
462015
Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: a mono-institutional …
F Lakosi, M de Cuypere, P Viet Nguyen, N Jansen, B Warlimont, ...
Acta oncologica 54 (9), 1558-1566, 2015
402015
Interobserver variability in organ at risk delineation in head and neck cancer
J Van der Veen, A Gulyban, S Willems, F Maes, S Nuyts
Radiation Oncology 16, 1-11, 2021
382021
Do results of the EORTC dummy run predict quality of radiotherapy delivered within multicentre clinical trials?
A Fairchild, L Collette, CW Hurkmans, B Baumert, DC Weber, A Gulyban, ...
European Journal of Cancer 48 (17), 3232-3239, 2012
352012
EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility
A Fairchild, E Aird, PA Fenton, V Gregoire, A Gulyban, D Lacombe, ...
Radiotherapy and Oncology 103 (3), 279-286, 2012
352012
Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial
L Paelinck, A Gulyban, F Lakosi, T Vercauteren, W De Gersem, ...
Radiotherapy and Oncology 122 (1), 30-36, 2017
342017
Improving generalization in MR‐to‐CT synthesis in radiotherapy by using an augmented cycle generative adversarial network with unpaired data
KND Brou Boni, J Klein, A Gulyban, N Reynaert, D Pasquier
Medical physics 48 (6), 3003-3010, 2021
292021
Setup accuracy for prone and supine whole breast irradiation
MD Thomas Mulliez, RN Annick van Greveling, BS RTT, ...
Strahlentherapie und Onkologie 192 (4), 254, 2016
262016
Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: first evaluation of quality of radiotherapy planning
E Musat, E Roelofs, R Bar-Deroma, P Fenton, A Gulyban, L Collette, ...
Radiotherapy and Oncology 95 (2), 218-224, 2010
262010
A simple clinical method for predicting the benefit of prone vs. supine positioning in reducing heart exposure during left breast radiotherapy
Z Kahán, F Rárosi, S Gaál, A Cserháti, K Boda, B Darázs, R Kószó, ...
Radiotherapy and Oncology 126 (3), 487-492, 2018
212018
Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome prediction
P Berkovic, L Paelinck, A Gulyban, M Van Eijkeren, V Surmont, Y Lievens, ...
Acta oncologica 56 (11), 1656-1659, 2017
212017
Respiratory Motion, Anterior Heart Displacement and Heart Dosimetry: Comparison Between Prone (Pr) and Supine (Su) Whole Breast Irradiation
F Lakosi, A Gulyban, L Janvary, SBM Simoni, N Jansen, L Seidel, ...
Pathology & Oncology Research 21, 1051-1058, 2015
212015
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20